Bayer: Well ahead of its guidance after Q1 but no increase, poor cash-flow

News published on April Tuesday 26, 2016
Share on

Bayer is reporting solid first-quarter earnings this morning, characterised by modest revenue performance overall but by an impressive margin improvement in all divisions, in line with what Covestro already disclosed yesterday for the Chemicals business. Now cash-flow generation was less impressive and despite a good performance in the first three months of the year, the group is not comfortable enough to change its guidance of mid-single digit earnings growth for the full-year.

For more information please contact

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities